STUDIO

BioStock Investor Pitch: Biosergen – vd Tine Kold Olesen 

BioStock Investor Pitch: Biosergen

In the BioStock Studio, Swedish Biosergen talks about the company’s vision, market plan and strategy to take its product through the first patient study...

RECOMMENDED READING

BioStock Investor Pitch: Biosergen – vd Tine Kold Olesen 

BioStock Investor Pitch: Biosergen

In the BioStock Studio, Swedish Biosergen talks about the company’s vision, market plan and...
Cline cartilage damage

Scientific Advisor on the potential of Cline’s cell therapy for cartilage...

Cline Scientific is developing a stem cell-based treatment for early cartilage damage to avoid...

EVENT